A detailed history of Martingale Asset Management L P transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Martingale Asset Management L P holds 34,797 shares of FATE stock, worth $57,763. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,797
Previous 34,797 -0.0%
Holding current value
$57,763
Previous $114,000 6.14%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$3.26 - $7.08 $2,891 - $6,279
887 Added 2.62%
34,797 $114,000
Q1 2024

May 14, 2024

BUY
$3.54 - $8.35 $120,041 - $283,148
33,910 New
33,910 $248,000

Others Institutions Holding FATE

About FATE THERAPEUTICS INC


  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $161M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Martingale Asset Management L P Portfolio

Follow Martingale Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.